IMDX

Insight Molecular Diagnostics Inc. specializes in precision diagnostics for oncology and transplantation. The company develops molecular diagnostic solutions that support clinical decision-making and translational research, focusing on early detection, treatment guidance, and monitoring therapeutic efficacy. Its product offerings include blood-based tests for transplant monitoring and assays for assessing tumor microenvironments in cancer patients. Insight Molecular Diagnostics operates primarily in the healthcare sector, serving researchers, clinicians, and healthcare systems globally.